NDC 71872-7357-01 - Lidocaine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7357
- Requested NDC
- 71872-7357-01
- Package NDCs from labels
- 71872-7357-1, 71872-7357-01
- Manufacturer
- Medical Purchasing Solutions, LLC.
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride Injection USP For Infiltration and Nerve Block Rx only | Medical Purchasing Solutions, LLC. | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7357-1 | Lidocaine Hydrochloride | 5 mL in 1 VIAL | SOLUTION | 5 | 1 | |
| 71872-7357-1 | Lidocaine Hydrochloride | 1 in 1 BAG | SOLUTION | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | f8d90500-f797-4238-8dd2-b59cbcd89d12 | 2026-04-23 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Sportpharm LLC | 2c58deba-dbb2-4e73-a173-36053536f03e | 2026-04-22 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 7adb9ab0-ef91-4c51-baa3-a0b7e12df077 | 2026-04-21 | Warnings, Adverse reactions | 1010033 V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Bryant Ranch Prepack | 8f79b023-9bd1-4bd6-8fd0-f9efe88abec0 | 2026-04-20 | Warnings, Adverse reactions | V13007Z41A |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Prostat First Aid | 4f9adbac-5497-e7be-e063-6294a90a7518 | 2026-04-16 | Warnings | V13007Z41A |
| Lidoease 2% | LIDOCAINE HCL 2% | PureTek Corporation | 3ba0c0ff-0f7a-7a29-e063-6294a90a547a | 2026-04-16 | Warnings | V13007Z41A |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Pain Relief Roll-On | LIDOCAINE 4% | Pharma Nobis, LLC | 4f6d9a51-c42e-ca88-e063-6394a90a8659 | 2026-04-14 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | c3490a23-14c4-43f7-b066-96a4c4298fde | 2026-04-14 | Warnings, Adverse reactions | V13007Z41A |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 9a1418e2-b208-4e5c-b5f8-21b3a691a578 | 2026-04-13 | Warnings, Adverse reactions | 1010033 1010671 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.